NCT02703740

Long Term Safety and Efficacy Assessment of Hyaluronic Acid Dermal Filler With for the Treatment of Nasolabial Folds

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Laboratoires Genévrier · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

This study evaluates the injection of a hyaluronic acid dermal filler with lidocaine 0.3% in the treatment of nasolabial folds (NLF). Each patient will receive 1 concentration in a NLF (20 mg/mL) and an other concentration in the other NLF (24 mg/mL).

Detailed description

Interventional, monocentric, double blind, randomised study Evaluation of safety the 1st month (primary criteria) and until 12 month Evaluation of performance at baseline, month 3, month 6, month 9 and month 12 : WSRS (wrinkle scale), profilometry (image measuring wrinkle depth and area), GAIS : satisfaction scale

Conditions

• Aesthetics

Interventions

Type	Name	Description
DEVICE	Hyaluronic acid dermal filler with lidocaine 0.3%	injection in labial fold of a dermal filler

Timeline

• Start date: 2016-01-11
• Primary completion: 2017-02-03
• Completion: 2017-02-03
• First posted: 2016-03-09
• Last updated: 2019-10-14

Locations

1 site across 1 country: France